HIMS Stock Under Pressure: BofA Warns Wegovy Churn Could Threaten Its Big H2 EBITDA Ramp
BofA flagged churn risk once subscription pricing jumps from $39 in month one to $149 in month two.
Read the full articleYou might also wanna read
Hims & Hers price target raised by $1 at BofA, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Kirby price target raised by $13 at BofA, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
IAMGold price target lowered by $1.50 at BofA, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Franco-Nevada price target lowered by $38 at BofA, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Cboe Global Markets price target lowered by $35 at Barclays
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
HSBC price target raised by 64 GBp at Morgan Stanley
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Comments
Sign in to join the conversation.
No comments yet. Be the first.